• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Controller Mcmullen James sold $145,780 worth of shares (4,000 units at $36.45), decreasing direct ownership by 65% to 2,132 units (SEC Form 4)

    5/8/25 4:23:26 PM ET
    $ACT
    Specialty Insurers
    Finance
    Get the next $ACT alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    McMullen James

    (Last) (First) (Middle)
    C/O ENACT HOLDINGS, INC.
    8325 SIX FORKS ROAD

    (Street)
    RALEIGH NC 27615

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Enact Holdings, Inc. [ ACT ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Controller
    3. Date of Earliest Transaction (Month/Day/Year)
    05/06/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/06/2025 S 4,000 D $36.445(1) 2,132 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Price indicated is the weighted average sale price as a result of a series of broker-assisted transactions ranging from $36.44 to $36.47 per share. The reporting person undertakes to provide full information regarding the number of shares purchased at each separate price within the range upon request by the SEC staff, the issuer, or any security holder of the issuer.
    Remarks:
    /s/ Joe Jacumin, by power of attorney 05/08/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ACT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ACT

    DatePrice TargetRatingAnalyst
    5/5/2025$39.00Outperform → Mkt Perform
    Keefe Bruyette
    12/6/2023$29.00Neutral
    UBS
    11/13/2023$30.00Neutral → Buy
    BofA Securities
    5/9/2023$25.00 → $27.00Underperform → Neutral
    BofA Securities
    2/8/2023$25.00 → $26.50Mkt Perform → Outperform
    Keefe Bruyette
    1/9/2023$24.50Neutral → Underperform
    Credit Suisse
    9/6/2022$27.00Overweight → Neutral
    JP Morgan
    8/18/2022$25.00Neutral → Underperform
    BofA Securities
    More analyst ratings

    $ACT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Controller Mcmullen James sold $145,780 worth of shares (4,000 units at $36.45), decreasing direct ownership by 65% to 2,132 units (SEC Form 4)

      4 - Enact Holdings, Inc. (0001823529) (Issuer)

      5/8/25 4:23:26 PM ET
      $ACT
      Specialty Insurers
      Finance
    • Large owner Genworth Holdings, Inc. sold $19,439,122 worth of shares (561,977 units at $34.59) (SEC Form 4)

      4 - Enact Holdings, Inc. (0001823529) (Issuer)

      5/1/25 4:16:34 PM ET
      $ACT
      Specialty Insurers
      Finance
    • Controller Mcmullen James converted options into 578 shares and covered exercise/tax liability with 166 shares, increasing direct ownership by 7% to 6,132 units (SEC Form 4)

      4 - Enact Holdings, Inc. (0001823529) (Issuer)

      4/3/25 4:13:50 PM ET
      $ACT
      Specialty Insurers
      Finance

    $ACT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Enact Reports First Quarter 2025 Results

      GAAP Net Income of $166 million, or $1.08 per diluted share Adjusted Operating Income of $169 million, or $1.10 per diluted share Return on Equity of 13.1% and Adjusted Operating Return on Equity of 13.4% Primary Insurance in-force of $268 billion, a 2% increase from first quarter 2024 PMIERs Sufficiency of 165% or approximately $2.0 billion Book Value Per Share of $33.96 and Book Value Per Share excluding AOCI of $34.97 RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced financial results for the first quarter of 2025. "We had a strong start to 2025 and continue to make progress against our priorities," stated Rohit Gupta, President a

      4/30/25 4:20:32 PM ET
      $ACT
      Specialty Insurers
      Finance
    • Genworth Financial Announces First Quarter 2025 Results

      Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

      4/30/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Enact Announces 14% Increase to Quarterly Dividend and New $350 Million Share Repurchase Program

      RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) announced that its Board of Directors declared a quarterly dividend of $0.21 per common share, an increase of 14% from the prior quarter's dividend. This dividend will be payable on June 11, 2025, to shareholders of record on May 19, 2025. Additionally, Enact's Board of Directors authorized a new share repurchase program under which the company may purchase up to $350 million of its common stock. The new share repurchase authorization is in addition to the company's current $250 million share repurchase program, of which $6 million remains as of April 25, 2025. "Our increased dividend and new share re

      4/30/25 4:10:00 PM ET
      $ACT
      Specialty Insurers
      Finance

    $ACT
    Leadership Updates

    Live Leadership Updates

    See more

    $ACT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $ACT
    SEC Filings

    See more
    • Enact Holdings Set to Join S&P SmallCap 600

      NEW YORK, April 9, 2025 /PRNewswire/ -- Enact Holdings Inc. (NASD: ACT) will replace SolarWinds Corp. (NYSE:SWI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, April 16. Turn/River Capital is acquiring SolarWinds in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector April 16, 2025 S&P SmallCap 600 Addition Enact Holdings ACT Financials April 16, 2025 S&P SmallCap 600 Deletion SolarWinds SWI Information Technology For more information about S&P Dow Jones Indices, please vi

      4/9/25 5:42:00 PM ET
      $ACT
      $SPGI
      $SWI
      Specialty Insurers
      Finance
      Finance: Consumer Services
      Computer Software: Prepackaged Software
    • Enact Announces Changes to its Board of Directors

      RALEIGH, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) today announced that it has appointed H. Elizabeth (Liz) Mitchell as an Independent Director to serve on Enact's Board of Directors, effective March 11, 2025. She has also been appointed as a member of the Audit Committee. In addition, the company announced that Anne G. Waleski has made the decision not to stand for re-election at the 2025 Annual Shareholder Meeting on May 14, 2025. As a result of these actions, Enact's Board will temporarily increase in size from eleven to twelve directors until the company's 2025 Annual Shareholder Meeting. Ms. Mitchell brings deep financial, industry and public

      3/11/25 4:15:00 PM ET
      $ACT
      Specialty Insurers
      Finance
    • Enact Holdings downgraded by Keefe Bruyette with a new price target

      Keefe Bruyette downgraded Enact Holdings from Outperform to Mkt Perform and set a new price target of $39.00

      5/5/25 8:29:05 AM ET
      $ACT
      Specialty Insurers
      Finance
    • UBS initiated coverage on Enact Holdings with a new price target

      UBS initiated coverage of Enact Holdings with a rating of Neutral and set a new price target of $29.00

      12/6/23 7:20:51 AM ET
      $ACT
      Specialty Insurers
      Finance
    • Enact Holdings upgraded by BofA Securities with a new price target

      BofA Securities upgraded Enact Holdings from Neutral to Buy and set a new price target of $30.00

      11/13/23 7:12:03 AM ET
      $ACT
      Specialty Insurers
      Finance
    • SEC Form 10-Q filed by Enact Holdings Inc.

      10-Q - Enact Holdings, Inc. (0001823529) (Filer)

      5/2/25 4:01:56 PM ET
      $ACT
      Specialty Insurers
      Finance
    • Enact Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

      8-K - Enact Holdings, Inc. (0001823529) (Filer)

      4/30/25 4:23:37 PM ET
      $ACT
      Specialty Insurers
      Finance
    • SEC Form DEFA14A filed by Enact Holdings Inc.

      DEFA14A - Enact Holdings, Inc. (0001823529) (Filer)

      3/28/25 6:43:25 AM ET
      $ACT
      Specialty Insurers
      Finance

    $ACT
    Financials

    Live finance-specific insights

    See more
    • Enact Reports First Quarter 2025 Results

      GAAP Net Income of $166 million, or $1.08 per diluted share Adjusted Operating Income of $169 million, or $1.10 per diluted share Return on Equity of 13.1% and Adjusted Operating Return on Equity of 13.4% Primary Insurance in-force of $268 billion, a 2% increase from first quarter 2024 PMIERs Sufficiency of 165% or approximately $2.0 billion Book Value Per Share of $33.96 and Book Value Per Share excluding AOCI of $34.97 RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced financial results for the first quarter of 2025. "We had a strong start to 2025 and continue to make progress against our priorities," stated Rohit Gupta, President a

      4/30/25 4:20:32 PM ET
      $ACT
      Specialty Insurers
      Finance
    • Genworth Financial Announces First Quarter 2025 Results

      Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

      4/30/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Enact Announces 14% Increase to Quarterly Dividend and New $350 Million Share Repurchase Program

      RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) announced that its Board of Directors declared a quarterly dividend of $0.21 per common share, an increase of 14% from the prior quarter's dividend. This dividend will be payable on June 11, 2025, to shareholders of record on May 19, 2025. Additionally, Enact's Board of Directors authorized a new share repurchase program under which the company may purchase up to $350 million of its common stock. The new share repurchase authorization is in addition to the company's current $250 million share repurchase program, of which $6 million remains as of April 25, 2025. "Our increased dividend and new share re

      4/30/25 4:10:00 PM ET
      $ACT
      Specialty Insurers
      Finance

    $ACT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Enact Holdings Inc. (Amendment)

      SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)

      2/13/24 4:15:14 PM ET
      $ACT
      Specialty Insurers
      Finance
    • SEC Form SC 13G/A filed by Enact Holdings Inc. (Amendment)

      SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)

      1/24/24 5:00:27 PM ET
      $ACT
      Specialty Insurers
      Finance
    • SEC Form SC 13G/A filed by Enact Holdings Inc. (Amendment)

      SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)

      2/13/23 12:30:19 PM ET
      $ACT
      Specialty Insurers
      Finance